The cloning of embryos for generating stem cells, a process that holds promise for the future treatment of deadly diseases such as diabetes and Parkinson's, is delicate yet straightforward.

One way to do this might be to combine Thomson's stem cell work with the cloning technology developed by Ian Wilmut and his colleagues at the Roslin Institute. (In 1997, Wilmut and his team ...

They warn of a brave new world of "embryo farms" and "cloning mills" for the cultivation of human spare parts. And they argue that scientists can achieve the same results using adult stem cells ...

the main tie of current ES cell research involves a more limited approach to such cloning—not to produce babies but for eventual use as a source in clinical procedures using tailored ES cells (t ...

Therapeutic cloning, also known as embryo cloning or somatic cell nuclear transfer (SCNT), involves creating embryonic stem cells that are genetically identical to the donor. The goal of therapeutic ...

They gave it a little electric shock to fuse the cell and get it replicating, placed the cells in the uterus of another sheep, and boom, clone. This method, called reproductive cloning ...

Whereas human cloning has been debated by politicians and ethicists largely in terms of its effects on society, children and our sense of personal identity, its deeper challenges lie in the realm ...

One of the creators of the world's first cloned mammal, Dolly the sheep, has died at the age of 79. Prof Sir Ian Wilmut's work, at the Roslin Institute in Edinburgh, laid the foundations for stem ...